Jamie Roe suffered a vaccine-induced blood clot but says 'the benefits outweigh the risks'.
As well as the online appeal, he is planning a fundraising bike ride between his home and the two hospitals where he was treated.
Mr Roe said he hopes to make a full recovery and will be returning to his job in the construction industry shortly.image caption The Oxford-AstraZeneca vaccine has been linked to distinctive, but rare, blood clots that also appear with low levels of platelets - which help clots form - in the blood.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid in Scotland: Inspectors highly critical of Covid-hit care homeDying residents' health needs were 'neglected' at the care home in Midlothian where 15 died with Covid.
Read more »
Deals and food freebies you can score with a COVID-19 vaccine cardCheck out the chains giving away the goods to reward those who got their vaccine.
Read more »
FDA Authorizes Pfizer COVID Vaccine for Kids 12-15This is the first COVID-19 vaccine in the U.S. authorized for use in younger teens and adolescents. In late March, Pfizer released results from a study that showed high antibody responses and 100% effectiveness against COVID-19.
Read more »
Marriott Points to Rising Demand Amid Covid-19 Vaccine RolloutThe hotel chain posted a quarterly loss of $11 million, though it saw demand in leisure travel pick up momentum, especially in ski and beach resort destinations.
Read more »
Teens Aged 12 to 15 Can Now Get Pfizer-BioNTech COVID-19 Vaccine in the U.S.The U.S. Food and Drug Administration (FDA) extended authorization of the Pfizer-BioNTech COVID-19 vaccine to 12- to 15-year-olds. It’s the first COVID-19 shot authorized for this younger population.
Read more »
EU won’t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedenceThe European Union hasn’t made any new orders for AstraZeneca’s COVID-19 vaccine beyond June when the contract ends. The EU agreed on a contract extension with Pfizer and BioNTech for a potential 1.8 billion doses through 2023.
Read more »